Video

Concluding Remarks in Lung Cancer Screening Following COVID-19

The 6-person panel concludes the discussion on lung cancer screening following the COVID-19 pandemic with an interactive question and answer session revolving around shared decision making, nonsmoker patient screening options, and molecular testing via standard tissue.

The 6-person panel concludes the discussion on lung cancer screening following the COVID-19 pandemic with an interactive question and answer session revolving around shared decision making, nonsmoker patient screening options, and molecular testing via standard tissue.

Related Videos
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Video 6 - "Reflex Testing for Patients with Suspected Lung Cancer"
Video 5 "Biomarker Testing in Early-Stage NSCLC"
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Related Content